Ascendis Pharma A (ASND) EBT Margin Growth (1y) (2015 - 2026)
Ascendis Pharma A (ASND) EBT Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ascendis Pharma A | 15.31 Bn | 14.64 Bn | 268.20 Mn | 7,314.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,314.00 |
| Dec 31, 2025 | 565.00 |
| Sep 30, 2025 | 14,291.00 |
| Jun 30, 2025 | 28,106.00 |
| Mar 31, 2025 | 4,135.00 |
| Dec 31, 2024 | 1,473.00 |
| Sep 30, 2024 | 16,662.00 |
| Jun 30, 2024 | -4,608.00 |
| Mar 31, 2024 | 19,232.00 |
| Dec 31, 2023 | 85,581.00 |
| Sep 30, 2023 | 76,971.00 |
| Jun 30, 2023 | 106,375.00 |
| Mar 31, 2023 | 150,811.00 |
| Dec 31, 2022 | -75,932.00 |
| Sep 30, 2022 | 611,250.00 |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 660,830.00 |
| Dec 31, 2021 | 7,782.00 |
| Sep 30, 2021 | -280,220.00 |
| Jun 30, 2021 | -653,655.00 |